PTC Therapeutics Inc. sell Citigroup Inc.
Start price
21.05.24
/
50%
€35.40
Target price
21.05.25
€23.95
Performance (%)
-12.43%
Price
29.08.24
€31.60
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. shows a convincing performance of -12.43%. This prediction currently runs until 21.05.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | 5.333% | 5.333% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Citigroup_Inc_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $18.00 to $26.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.60
27.10.23
27.10.23
€16.10
27.10.24
27.10.24
78.41%
29.08.24
29.08.24